NEW YORK (GenomeWeb News) – Genentech has licensed Genizon Biosciences’ GeneMap of Crohn’s disease to support drug and diagnostics development, Genizon said today.
 
Under the agreement, Genizon will receive an undisclosed upfront payment, research funding, and milestone payments for each therapeutic developed through the collaboration.
 
GeneMap’s disease-associated genes were generated from a whole genome association study of 500 families from the Quebec Founder Population.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Though many details have yet to be worked out, the draft deal for the UK's withdrawal from the EU is giving researchers some hints for what they can expect, Nature News says.

DNA testing has solved a 100-year-old mystery contained in the skull and teeth samples of a now-extinct monkey that once inhabited Jamaica, Gizmodo reports.

As the UN ponders a ban on gene drives, one malaria researcher says there are less dramatic ways to fight the disease in Africa than unleashing GM mosquitoes on a whole continent.

In Nature this week: an improved reference genome of the Aedes aegypti mosquito, genomes of four species of truffles, and more.